Dr. Gray has authored over 300 peer-reviewed publications. For the full list of all his publications, please visit his publication list on PubMed.

Fan, Y., Ge, N., Wang, X., Sun, W., Mao, R., Bu, W., Creighton, C.J., Zheng, P., Vasudevan, S., An, L. Yang, J., Zhao, Y.-J., Zhang, H., Li, X.-N., Rao, P.H., Leung, E., Lu, Y.-J., Gray, J.W., Schiff, R., Hilsenbeck, S.G., Osborne,C.K., Yang, J., and Zhang, H. (2013) Amplification and overexpression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells. J. Pathol., 232:75-86. PMC3966110

Griffith, O.L., Pepin, F., Enache, O.M., Heiser, L.M., Collisson, E.A.,Spellman, P.T., Gray, J.W. (2013) A robust prognostic signature for hormone-positive node-negative breast cancer. Genome Med., 5:92. PMC3961800

Timmerman, L., Holton, T., Daemen, A., Hu, M., Yuneva, M., Ethier, S., van 't Veer, L., Polyak, K., McCormick, F., Gray, J. (2013) Glutamine sensitivity analysis identifies the xCT antiporter as a triple-negative breast tumor therapeutic target. Cancer Cell, 24:450-65. PMC3931310

Fallahi-Sichani, M., Honarnejad, S., Heiser, L.M., Gray, J.W., Sorger, P.K. (2013) Metrics other than potency reveal systematic variation in responses to cancer drugs. Nat. Chem. Biol., 9:708-14. PMC3947796

Iacovides, D.C., Johnson, A.B., Wang, N., Boddapati, S., Korkola, J., Gray,J.W. (2013) Identification and quantification of AKT isoforms and phosphoforms in breast cancer using a novel nanofluidic immunoassay. Mol. Cell. Proteomics,12:3210-20. PMC3820934

Rhee, J.-K., Kim, K., Chae, H., Evans, J., Yan, P., Zhang, B.-T., Gray, J.,Spellman, P., Huang, T.H., Nephew, K.P., Kim, S. (2013) Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer. Nucleic Acids Res., 41:8464-74. PMC3794600

Fan, P., Griffith, O.L., Agboke, F., Anur, P., Zou, X., Creswell, K., Kim,S.H., Katzenellenbogen, J.A., Gray, J.W., Jordan, V.C. (2013) c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells.Cancer Res. 73:4510-20. PMC3715569

Sadanandam, A., Lyssiotis, C.A., Homicsko, K., Collisson, E.A., Gibb, W.J.,Wullschleger, S., Ostos, L.C., Lannon, W.A., Grotzinger, C., Del Rio, M.,Lhermitte, B., Olshen, A.B., Wiedenmann, B., Cantley, L.C., Gray, J.W., Hanahan, D. (2013) A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med., 19:619–625. PMC3774607

LeBeau, A.M., Duriseti, S., Murphy, S.T., Pepin, F., Hann, B., Gray, J.W.,Vanbrocklin, H.F., Craik, C.S. (2013) Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer. Cancer Res., 73:2070–81. PMC3618559

Verhaak, R., Tamayo, P., Creighton, C.J., Yang, J.Y., Hubbard, D., Zhang, H., Fereday, S., Lawrence, M., Carter, S.L., Mermel, C., Kostic, A.D., Etemadmoghadam, D., Saksena, G., Cibulskis, K., Duraisamy, S., Levanon, K., Sougnez, C., Tsherniak, A., Gomez, S., Onofrio, R.C., Gabriel, S.B., Chin, L., Zhang, N., Spellman, P.T., Zhang, Y., Akbani, R., Hoadley, K.A., Kahn, A.,Köbel, M., Huntsman, D.G., Soslow, R.A., deFazio, A., Birrer, M.J., Gray, J.W., Weinstein, J.N., Bowtell, D.D., Drapkin, R.I., Mesirov, J., Getz, G., Levine, D.A., and Meyerson M. (2013) Prognostically relevant gene expression signatures of high grade serous ovarian carcinoma. J. Clin. Invest., 123:517-25. PMC3533304

Chang, H., Han, J., Borowsky, A.D., Loss, L., Gray, J.W., Spellman, P.T., Parvin, B. (2013) Invariant delineation of nuclear architecture in glioblastomamultiforme for clinical and molecular association. IEEE Trans. Med. Imaging., 32:670-82. PMC3728287